Duquesne Family Office »

Belite Bio shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 106k 159.44

More positions owned by Duquesne Family Office

Natera (NTRA)
Ishares Msci Brazil Etf (EWZ)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Call Option (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Bbb Foods Cl A Com (TBBB)
Alcoa (AA)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Sea Sponsord Ads (SE)
Stmicroelectronics N V Ny Registry (STM)
Woodward Governor Company (WWD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Roku Com Cl A (ROKU)
Broadcom (AVGO)

View all positions for Duquesne Family Office

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio